Company / Operating Cash Flow per Share
Haemonetics Operating Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.60
FY2024
5-year range
$3.35 / $5.31
FY2020-FY2024
Trend
+1.9%
vs FY2023
Sector context
#67 of 155
Health Care
What the data says
At $3.60, Haemonetics's operating cash flow per share ranks #67 of 155 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $2.12 in FY2020 to $5.31 in FY2022.
Based on SEC 10-K filings.
3.60 in FY2024 with a 5-year CAGR of +3.4%.
Declined from $5.31 to $3.60 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Sector benchmark
#67 of 155 in Health CareTop 43% of 155This company $3.60 Sector average $6.77
▼
-46.8% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 1.9% year-over-year.
- Ranks #67 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $3.60 | +1.9% |
| FY2023 | $3.54 | -33.4% |
| FY2022 | $5.31 | +58.3% |
| FY2021 | $3.35 | +58.1% |
| FY2020 | $2.12 | -30.5% |
| FY2019 | $3.05 | +0.2% |
| FY2018 | $3.05 | -29.5% |
| FY2017 | $4.33 | +39.9% |
| FY2016 | $3.09 | +32.0% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026